A new genetic screen may be able to predict low bone-mineral density, osteoporosis and fracture risk prior to clinical symptoms, according to a retrospective study of nearly 400,000 people by a Stanford researcher.
The findings suggest that patients with a serious illness are more at ease with decisions about their care when they discuss their care preferences with someone outside the medical context, according to Stanford researchers.
Inside Stanford Medicineis a twice-monthly newspaper that reports on the accomplishments and activities of the faculty, staff and students in the Stanford Medicine community. To suggest a story or to get more information, contact editor John Sanford at (650) 723-8309 or email@example.com.
You're receiving this newsletter because you registered with us.
Not interested anymore? Unsubscribe here.